MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2022 International Congress

    Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia

    P. Wongwan, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the goal attainment scale (GAS) by interviewing the three most disturbing problems and changes after Botulinum toxin A injection in cervical dystonia…
  • 2022 International Congress

    Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia

    A. Silbergleit, L. Schultz, K. Isabell, J. Turnbull, E. Boettcher, R. Konnai, C. Sidiropoulos, N. Patel (West Bloomfield, USA)

    Objective: 1.To determine if Botulinum toxin (BoNT) injection improves oropharyngeal swallowing in individuals with cervical dystonia (CD) as determined by objective data from videofluorographic swallowing studies…
  • 2022 International Congress

    PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA

    A. Trinchillo, G. de Joanna, M. Esposito (Naples, Italy)

    Objective: This is the phenotypic description of two families affected by hereditary dystonia associated to gene ANO3 mutation (DYT24), one with a heterozygous verisimilarly pathogenic…
  • 2022 International Congress

    Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia

    B. Waeschle, H. Stark, P. Albrecht (Düsseldorf, Germany)

    Objective: We conducted a survey to characterize real-world treatment of CD patients with focus on treatment duration, clinical parameters and awareness of clinical resistance as…
  • 2022 International Congress

    Does needle size matter in botulinum toxin injection? A crossover randomised controlled trial of microneedle in patients with hemifacial spasm

    S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (bangkok, Thailand)

    Objective: The aim of this study was to compare the severity of  pain and bruises between a microneedle (34-G) and standard needle (30-G) in patients…
  • 2022 International Congress

    Evaluation of Atrophy after Botulinum Toxin injection for Cervical Dystonia by MRI

    M. Salari, M. Etemadifar, S. Parvizi (Tehran, Islamic Republic of Iran)

    Objective: Cervical Dystonia (CD) is the most common form of focal dystonia involving the muscles of the neck and sometimes the shoulders. 1 There are several categories…
  • 2022 International Congress

    Late-onset Treatment Resistant Isolated Oromandibular Dystonia: A case report

    S. Jain, P. Renjen, D. Chaudhary, S. Pandey, A. Goswami (New Delhi, India)

    Objective: We hereby report a case of oromandibular dystonia with onset in late 70s and symptoms resistant to symptomatic therapy including onabotulinum toxin A. Background:…
  • 2022 International Congress

    Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis Subtype of Cervical Dystonia

    K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)

    Objective: To describe characteristics and treatment response of patients with anterocollis (AC) treated with onabotulinumtoxinA (onabotA). Background: CD-PROBE included onabotA-treated patients with AC, providing an…
  • 2022 International Congress

    Adult-onset axial dystonia: a rare condition that can lean on an early combined treatment approach

    P. Mitrotti, G. Vaghi, V. Grillo, C. Susca, R. de Icco, M. Allena, M. Avenali, C. Tassorelli (Pavia, Italy)

    Objective: To describe a rare case of adult-onset axial dystonia treated successfully with a  combined therapeutic approach. Background: Adult-onset truncal dystonia is an unusual condition…
  • 2022 International Congress

    The effects of converting to Dysport from other botulinum toxin type A formulations for treating cervical dystonia patients

    O. Samotus, M. Jog (London, Canada)

    Objective: To investigate whether Dysport increases waning time compared to other botulinum toxin type A (BoNT-A) formulations for cervical dystonia (CD) therapy. Background: BoNT-A injections…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley